| David Flarry, NP | |
|
2979 Squalicum Pkwy, Bellingham, WA 98225-1811 | |
| (360) 734-2700 | |
| Not Available |
| Full Name | David Flarry |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2979 Squalicum Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013514488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | AP61081914 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 9537073960 | 259 |
News Archive
pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, today said it had received full payment of a $15 million note, including an additional $225,000 in accrued interest, from Alimera Sciences, Inc., pSivida's licensee developing Iluvien® for the treatment of diabetic macular edema (DME).
The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Targeted Genetics Corporation (the "Company") today announced that it has received a written notice from the staff of The NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on Thursday, January 21, 2010, and that NASDAQ would initiate procedures to delist the Company's common stock.
› Verified 1 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, today said it had received full payment of a $15 million note, including an additional $225,000 in accrued interest, from Alimera Sciences, Inc., pSivida's licensee developing Iluvien® for the treatment of diabetic macular edema (DME).
The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Targeted Genetics Corporation (the "Company") today announced that it has received a written notice from the staff of The NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on Thursday, January 21, 2010, and that NASDAQ would initiate procedures to delist the Company's common stock.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Flarry, NP 2924 Huntington St, Bellingham, WA 98226-8631 Ph: (360) 920-0422 | David Flarry, NP 2979 Squalicum Pkwy, Bellingham, WA 98225-1811 Ph: (360) 734-2700 |
News Archive
pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, today said it had received full payment of a $15 million note, including an additional $225,000 in accrued interest, from Alimera Sciences, Inc., pSivida's licensee developing Iluvien® for the treatment of diabetic macular edema (DME).
The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Targeted Genetics Corporation (the "Company") today announced that it has received a written notice from the staff of The NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on Thursday, January 21, 2010, and that NASDAQ would initiate procedures to delist the Company's common stock.
› Verified 1 days ago
Melanie R Hartley, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy, Suite 1e, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5679 | |
Rachel Hill May, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Jody L Bauer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3111 Woburn St Ste 201, Bellingham, WA 98226 Phone: 360-734-1420 Fax: 360-733-1659 | |
Amanda Vichas, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-756-9793 Fax: 360-752-9007 | |
Graham Meeks, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2979 Squalicum Pkwy Ste 101, Bellingham, WA 98225 Phone: 360-734-2700 Fax: 360-734-8362 | |
Jaspreet S Khehra, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Unity St, Bellingham, WA 98225 Phone: 360-676-6177 |